Outlook Therapeutics Inc (OTLK)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current OTLK market cap is 187.01M. The company's latest EPS is USD -2.5200 and P/E is -3.14.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.86M | -18.15M | -12.47M | -10.32M | -18.97M |
| Net Income | -6.65M | -20.68M | -12.99M | -11.18M | -114.29M |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 8.15M | 0 | 0 | 0 | 0 |
| Operating Income | -36.3M | -36.84M | -51.77M | -63.12M | -53.14M |
| Net Income | -36.04M | -48.87M | -53.16M | -66.05M | -58.98M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 54.02M | 44.45M | 32.3M | 21.69M | 59.03M |
| Total Liabilities | 43.54M | 49.95M | 46.74M | 46.03M | 193.27M |
| Total Equity | 10.49M | -5.5M | -14.44M | -24.34M | -134.24M |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 17.14M | 19.73M | 22.81M | 28.53M | 32.3M |
| Total Liabilities | 27.91M | 16.91M | 18.2M | 19.79M | 46.74M |
| Total Equity | -16.13M | 2.83M | 4.61M | 8.74M | -14.44M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -17.02M | -30.23M | -42.97M | -13.03M | -32.3M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 43.25M | 46.54M | 48.97M | -3k | 56.14M |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -32.29M | -31.79M | -54.25M | -56.67M | -42.97M |
| Investing | -437k | -900k | N/A | N/A | N/A |
| Financing | 39.03M | 37.21M | 56.19M | 59.59M | 48.97M |
| Market Cap | 187.01M |
| Price to Earnings Ratio | -3.14 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 7.92 |
| Price to Book Ratio | -12.84 |
| Dividend Yield | - |
| Shares Outstanding | 23.41M |
| Average Volume (1 week) | 221.76k |
| Average Volume (1 Month) | 236.93k |
| 52 Week Change | -76.77% |
| 52 Week High | 34.80 |
| 52 Week Low | 4.004 |
| Spread (Intraday) | 0.03 (0.38%) |
| Company Name | Outlook Therapeutics Inc |
| Address |
800 north state street dover, delaware 19901 |
| Website | https://www.outlooktherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
